Molecular Diagnostics Market Top Key Player Analysis - Abbott, Alere, Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories, Danaher Corporation, GenMark Diagnostics & more

MarketStudyReport.com Adds New Molecular Diagnostics Market 2017 – 2024 research report providing information and By Application, By Technology, Industry Analysis, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 270 Pages with table and figures in it.

Molecular Diagnostics Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 8.4% CAGR to 2024.

Molecular Diagnostics Market is set to exceed USD 12.5 billion by 2024; according to a new research report. Growing geriatric population base along with rising incidences of infectious diseases will act as high impact rendering factors for molecular diagnostics market. Elderly people prone to suffer from several diseases require continuous monitoring as well as diagnostic tests for various diseases. Multifactorial benefits and applications of molecular diagnostics in therapeutic monitoring, detection of predisposition to disease, patient stratification, drug regimen selection and others will drive molecular diagnostics market growth.

Technological advancements including target specific PCR, high throughput capacity has escalated level of disease diagnosis in less time as compared to conventional method will favor molecular diagnostics market growth. Growing awareness about several diseases, diagnosis and prevention has stimulated demand for diagnostic tests.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467710/

Growing adoption of western culture, unhealthy dietary habits and physical inactivity has led to upsurge in several chronic disease incidences. Increasing prevalence of infectious diseases in developing countries such as India coupled with growing demand for point of care diagnostic technologies (POCT) will fuel business growth.

Growth of home healthcare sector coupled with technological advancements in handheld POCT devices will drive molecular diagnostics market growth.
Rising demand for cost effective disease diagnostic tests has accelerated rise in R&D investment for development of molecular diagnostic platform. Significant role of molecular testing in diagnosis of cancer and sexually transmitted disease will positively impact industry growth. However, complex nature of U.S. FDA approval for molecular diagnostic technology coupled with rising costs associated with molecular testing will hinder molecular diagnostics market growth over the forecast period.

Infectious disease segment held largest revenue share in 2016 and is expected to follow similar trend over the forecast timeframe due to increasing incidences of infectious diseases in developing countries of Asia Pacific and Latin America. Growing awareness about pre-disease diagnosis will fuel molecular diagnostics market growth.

U.S. molecular diagnostics market held largest revenue share in 2016 due to growing geriatric population, highly susceptible to suffer from various illnesses along with high technological adoption rate of U.S. Increasing healthcare expenditure by government as well as individual will positively impact market growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467710/

China molecular diagnostics market should grow at significant rate due to growing demand for advanced treatment coupled with rising prevalence of infectious diseases such as hepatitis in the country. Increasing number of baby boomers will act as primary driver for industry growth. Increasing focus of industry players towards expanding country's molecular diagnostics platform coupled with rising adoption of PCR and locally manufactured diagnostic kits in the country will favor Chine molecular diagnostics market growth.

Some of the key industry players operating in global molecular diagnostics market are Abbott, Alere, Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories, Danaher Corporation, GenMark Diagnostics, HTG Molecular Diagnostics, Johnson & Johnson, MDxHealth, Novartis (Grifols), Qiagen Gaithersburg, Siemens Healthcare and Roche. Industry players are focusing their efforts towards developing new cost-effective, highly accurate and easy operative molecular diagnostic products to satisfy increasing consumer demand along with consolidate its market position. Strategic partnership, alliances, mergers and acquisitions are major strategies followed by market players.

Table of Content:

Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Molecular Diagnostics Industry Insights
Chapter 4. Molecular Diagnostics Market, By Application
Chapter 5. Molecular Diagnostics Market, By Technology
Chapter 6. Molecular Diagnostics Market, By Region
Chapter 7. Company Profiles

For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

Related Report:

Global In Vitro Diagnostics (IVDs) Market Research Report 2018

This report studies the global In Vitro Diagnostics (IVDs) market status and forecast, categorizes the global In Vitro Diagnostics (IVDs) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

https://www.marketstudyreport.com/reports/global-in-vitro-diagnostics-ivds-market-research-report-2018/?utm_source=RR-PSR

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

This release was published on openPR.